Anthrax: Difference between revisions

Line 39: Line 39:


==Treatment==
==Treatment==
#[[Cipro]] 500 mg bid or 30 mg/kg div q12
{{Anthrax antibiotics}}
##(Peds)-20-30mg/kg IV q12h
#[[Levo]] 500 mg qd
#[[Doxycycline]] 100 mg bid
##(Peds) 2.5mg/kg IV q12h
#x 60 days
 
PLUS vaccine: inactivated, cell-free immediately, 2 wks and then 4 wks
 
===Prophylaxis===
#[[Cipro]] (Adult)-500mg PO BID
##(Peds)-20-30mg/kg/d PO BID
#[[Doxy]] (Adult) 100mgPO BID
##(Peds) 2.5mg/kg PO BID


==See Also==
==See Also==

Revision as of 03:09, 26 April 2015

Background

  1. Gm positive rod, tough spores
  2. Inhalational Anthrax: Russian accident at Sverdlovsk
  3. Incubation Period is 10 days
  4. No one < 24 died

Differential Diagnosis

  1. Cutaneous (painless)
    1. Ecthyma gangrenosum
    2. Rat-bite fever (Streptobacillus monilifomis and Spirillum minus)
    3. Ulceroglandular tularemia
    4. Plague
    5. Glanders (Pseudomonas peudomallei)
    6. Rickettsialpox (Rickettsia akari)
    7. Orf (parapox virus)
    8. Staph lymphadenitis
    9. TB
    10. Leprosy
    11. Buruli ulcer (Mycobact ulcerans)
  2. Inhalational
    1. Acute bacterial mediastinitis
    2. Mycoplasma
    3. Legionnaire's
    4. Psittacosis
    5. Tularemia
    6. Q fever (Coxiella burnetti)
    7. Viral pneumonia
    8. Histoplasmosis
    9. Coccidiomycosis
    10. Ruptured Aortic Dissection
    11. SVC syndrome
    12. Silicosis
    13. Sarcoidosis

Lower Respiratory Zoonotic Infections

Imaging

CXR/CT- Widened mediastinum representing hemorrhagic mediastinitis

Treatment

Postexposure Prophylaxis

Patient should be vaccinated at day #0, #14, #28

Cutaneous Anthrax (not systemically ill)

Inhalation or Cutaneous with systemic illness

Pediatric Postexposure Prophylaxis

Pediatric Cutaneous Anthrax (not ill)

  • Same as pediatric postexposure dosing and duration

Pediatric Inhalational or Cutaneous (systemically ill)

  • Ciprofloxacin 15mg/kg IV q12hrs OR
  • Doxycycline 2.2mg/kg IV q12hrs PLUS
  • Imipenem/Cilastatin 1g IV q6h for at least 2wk
  • Imipenem/Cilastatin Neonates >32 wk gestation; 40-75 mg/kg/day IV divided q8-12h for at least 2wk; 1 month and older; 100 mg/kg/day IV divided q6h for at least 2wk
  • Rifampin 600 mg IV q12h for at least 2 wk as part of a multi-drug regimen; Switch to PO abx x60 days total if inhalational exposure
  • Rifampin Neonates >32 wk gestation; 10-20 mg/kg/day IV divided q12-24h for at least 2 wk as part of multi-drug regimen; 1+ mo; 20 mg/kg/day IV divided q12h for at least 2 wk as part of multi-drug regimen; Max: 300 mg/dose
  • Imipenem/Cilastatin 1g IV q6h for at least 2wk
  • Imipenem/Cilastatin Neonates >32 wk gestation; 40-75 mg/kg/day IV divided q8-12h for at least 2wk; 1 month and older; 100 mg/kg/day IV divided q6h for at least 2wk
  • Rifampin 600 mg IV q12h for at least 2 wk as part of a multi-drug regimen; Switch to PO abx x60 days total if inhalational exposure
  • Rifampin Neonates >32 wk gestation; 10-20 mg/kg/day IV divided q12-24h for at least 2 wk as part of multi-drug regimen; 1+ mo; 20 mg/kg/day IV divided q12h for at least 2 wk as part of multi-drug regimen; Max: 300 mg/dose

See Also

Bioterrorism

Source